Preview

Hygiene and Sanitation

Advanced search
Open Access Open Access  Restricted Access Subscription Access

Expression of CD11a+ and CD309+ membrane lymphocyte clusters as biomarkers of the effect of combined exposure to benzo(a)pyrene and cold factor in experimental in vivo models

https://doi.org/10.47470/0016-9900-2025-104-4-459-462

EDN: iawdga

Abstract

Introduction. It is relevant to investigate expression of CD11a+ and CD309+ markers under combined exposure to benzo(a)pyrene and cold factor in an in vivo experiment in terms of modelling likely effects and verifying mechanisms of the developing of disorders of endothelial immune regulation caused by biological exposure to benzo(a)pyrene in northern areas.

Materials and methods. An in vivo subchronic experiment was performed using forty eight nonlinear laboratory mice divided into 4 groups according to the conditions of factor loading (oral biological exposure to benzo(a)pyrene at an average daily dose of 0.175 mcg/kgday; exposure to cold, average daily air temperature 9.9±2.6 °C). The content of CD11a+ and CD309+ lymphocytes was determined by flow cytofluorometry.

Results. The results of oral subchronic biological exposure to benzo(a)pyrene at a dose of 0,175 µg/kg×day under cold stress in an in vivo experiment made it possible to establish CD309+ lymphocytes overexpression against the background of CD11a+ cells decrease (OR=5.00–22.50; RR=2.63–4.20; p=0.001–0.042). An increase in CD309+ lymphocytes content by 62% relative to the control is mainly associated with biological exposure to benzo(a)pyrene (OR=11.25 (1.65-76.85); RR=2.86 (1.20–6.86); p=0.026) while a decrease in CD11a+ lymphocyte content is associated with cold stress (OR=11.00 (1.77–68.35); RR=3.50 (1.22–10.05), p=0.001). Combined exposure to benzo(a)pyrene and cold forms synergistic, more than additive effects in the cellular immune profile (OR=14.67–22.50; RR=3.15–4.20; p=0.001–0.042).

Limitations. The limitations are related to quantitative parameters of the sample, limited choice of exposure factors, and the need for subsequent confirmation of obtained results.

Conclusion. Thus, the imbalance of adaptive cellular immune profile identified in in vivo models (CD309+ activation, CD11a+ deficiency) reflects the launch of negative inflammatory and proliferative scenarios associated with cardiovascular diseases. This makes it possible to verify mechanisms of cold and chemical (benzo(a)pyrene) stress formation and recommend CD11a+ and CD309+ lymphocyte clusters to be used as biomarkers of the effect for biological exposure to benzo(a)pyrene in northern areas.

Compliance with ethical standards. The study was conducted in compliance with the requirements of the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (ETS No. 123) and the Local Ethics Committee of the Federal Research Center for Medical and Preventive Health Risk Management Technologies (The meeting protocol No. 2 dated January 17, 2022).

Contribution:
Dolgikh O.V. study concept and design, editing the text;
Nikonoshina N.A. data collection and analysis, writing the text.
All authors are responsible for the integrity of all parts of the manuscript and for the approval of its final version.

Conflict of interest. The authors declare no conflict of interest.

Acknowledgement. The study had no sponsorship.

Received: February 17, 2024 / Revised: March 6, 2024 / Accepted: March 26, 2025 / Published: April 30, 2025

About the Authors

Oleg V. Dolgikh
Federal Scientific Center for Medical and Preventive Health Risk Management Technologies
Russian Federation

DSc (Medicine), Professor, Head of the Department of Immunobiological Diagnostic Methods of Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation

e-mail: oleg@fcrisk.ru



Natalya A. Nikonoshina
Federal Scientific Center for Medical and Preventive Health Risk Management Technologies
Russian Federation

Researcher of the Department of Immunobiological Diagnostic Methods of Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation

e-mail: nat08.11@yandex.ru



References

1. Guan S., Huang Y., Feng Z., Xu L., Jin Y., Lu J. The toxic effects of benzo[a]pyrene on activated mouse T cells in vitro. Immunopharmacol. Immunotoxicol. 2017; 39(3): 117–23. https://doi.org/10.1080/08923973.2017.1299173

2. Abd El-Fattah E.E., Abdelhamid A.M. Benzo[a]pyrene immunogenetics and immune archetype reprogramming of lung. Toxicology. 2021; 463: 152994. https://doi.org/10.1016/j.tox.2021.152994

3. Shur P.Z., Khasanova А.А., Tsinker М.Yu., Zaitseva N.V. Methodical approaches to assessing public health risks under combined exposure to climatic factors and chemical air pollution caused by them. Health Risk Analysis. 2023; (2): 58–68. https://doi.org/10.21668/health.risk/2023.2.05 (in Russian)

4. Litovchenko O.G., Gadzhibekova N.G. Functional features of the cardiorespiratory system of the alien population living in the regions of the Far North and areas equated to them (literature review). Rossiiskie biomeditsinskie issledovaniya. 2023; 8(3): 36–49. https://doi.org/10.56871/RBR.2023.19.40.006 (in Russian)

5. Ganeshan K., Chawla A. Warming the mouse to model human diseases. Nat. Rev. Endocrinol. 2017; 13(8): 458–65. https://doi.org/10.1038/nrendo.2017.48

6. Mohammadpour H., MacDonald C.R., Qiao G., Chen M., Dong B., Hylander B.L., et al. β2 adrenergic receptor–mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J. Clin. Invest. 2019; 129(12): 5537–52. https://doi.org/10.1172/JCI129502

7. Bond L.M., Burhans M.S., Ntambi J.M. Uncoupling protein-1 deficiency promotes brown adipose tissue inflammation and ER stress. PloS One. 2018: 13(11): e0205726. https://doi.org/10.1371/journal.pone.0205726

8. Szentirmai É., Kapás L. Sleep and body temperature in TNFalpha knockout mice: the effects of sleep deprivation, beta3-AR stimulation and exogenous TNFalpha. Brain Behav. Immun. 2019; 81: 260–71. https://doi.org/10.1016/j.bbi.2019.06.022

9. Sharaveva I.L., Gein S.V. Influence of acute cold stress on the secretion of IL-2, IL-4, IFNγ, IL-12 in vivo by mouse splenocytes. Meditsinskaya immunologiya. 2022; 24(4): 843–8. https://doi.org/10.15789/1563-0625-IOA-2383 https://elibrary.ru/jnocjj (in Russian)

10. Alikina I.N., Dolgikh O.V. Features of the cytokine profile under its modification with technogenic factors in conditions of experiment in vitro (on the example of benz(a)pyrene and SARS-CoV-2 vaccine antigen). Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal). 2023; 102(5): 421–5. https://doi.org/10.47470/0016-9900-2023-102-5-421-425 https://elibrary.ru/icmpiz (in Russian)

11. Bouayed J., Bohn T., Tybl E., Kiemer A.K., Soulimani R. Benzo[α]pyrene-induced anti-depressive-like behaviour in adult female mice: role of monoaminergic systems. Basic Clin. Pharmacol. Toxicol. 2012; 110(6): 544–50. https://doi.org/10.1111/j.1742-7843.2011.00853.x

12. Hou L., Yuki K. CD11a regulates hematopoietic stem and progenitor cells. Front. Immunol. 2023; 14: 1219953. https://doi.org/10.3389/fimmu.2023.1219953

13. Guerrero-García J.J. The role of astrocytes in multiple sclerosis. Neurología. 2020; 35(6): 400–8. https://doi.org/10.1016/j.nrl.2017.07.021

14. Fekadu J., Modlich U., Bader P., Bakhtiar S. Understanding the role of LFA-1 in leukocyte adhesion deficiency type I (LAD I): Moving towards Inflammation? Int. J. Mol. Sci. 2022; 23(7): 3578. https://doi.org/10.3390/ijms23073578

15. Lei F., Tian Y., Miao J., Pan L., Tong R., Zhou Y. Immunotoxicity pathway and mechanism of benzo[a]pyrene on hemocytes of Chlamys farreri in vitro. Fish Shellfish Immunol. 2022; 124: 208–18. https://doi.org/10.1016/j.fsi.2022.04.009

16. Wang L., Ge H., Peng L., Wang B. A meta-analysis of the relationship between VEGFR2 polymorphisms and atherosclerotic cardiovascular diseases. Clin. Cardiol. 2019; 42(10): 860–5. https://doi.org/10.1002/clc.23233

17. Marques C.S., Brandão P., Burke A.J. Targeting vascular endothelial growth factor receptor 2 (VEGFR-2): Latest insights on synthetic strategies. Molecules. 2024; 29(22): 5341. https://doi.org/10.3390/molecules29225341

18. Luck R., Urban S., Karakatsani A., Harde E., Sambandan S., Nicholson L., et al. VEGF/VEGFR2 signaling regulates hippocampal axon branching during development. Elife. 2019; 8: e49818. https://doi.org/10.7554/eLife.49818

19. Wang X., Bove A.M., Simone G., Ma B. Molecular bases of VEGFR-2-mediated physiological function and pathological role. Front. Cell Dev. Biol. 2020; 8: 599281. https://doi.org/10.3389/fcell.2020.599281

20. Lugano R., Ramachandran M., Dimberg A. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell. Mol. Life Sci. 2020; 77(9): 1745–70. https://doi.org/10.1007/s00018-019-03351-7

21. Prasad C.B., Singh D., Pandey L.K., Pradhan S., Singh S., Narayan G. VEGFa/VEGFR2 autocrine and paracrine signaling promotes cervical carcinogenesis via β-catenin and snail. Int. J. Biochem. Cell Biol. 2022; 142: 106122. https://doi.org/10.1016/j.biocel.2021.106122


Review

For citations:


Dolgikh O.V., Nikonoshina N.A. Expression of CD11a+ and CD309+ membrane lymphocyte clusters as biomarkers of the effect of combined exposure to benzo(a)pyrene and cold factor in experimental in vivo models. Hygiene and Sanitation. 2025;104(4):459-462. (In Russ.) https://doi.org/10.47470/0016-9900-2025-104-4-459-462. EDN: iawdga

Views: 75


ISSN 0016-9900 (Print)
ISSN 2412-0650 (Online)